FDA Inspection 1153161 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on September 23, 2021 in Tuscaloosa, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 23, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tuscaloosa, AL (United States)